INTRODUCTION
The role of diet in human health remains controversial.
The contribution to human health of the specific fatty acid (FA) composition of the diet has received considerable attention in the literature. Fatty acids are key nutrients that affect early growth and development as well as the prevention of chronic disease in later life. 1 Among the FAs, Omega-3 polyunsaturated fatty acids (n-3 PUFA) and omega-6 polyunsaturated fatty acids (n-6 PUFA) have been suggested to decrease and increase several human diseases, respectively. PUFA that contains more than one carbon double bond consists of two major classes such as n-6 and n-3 ( PUFA, as diet-dependent factors, may be critical to preventing disease backed up with authentic antioxidative and anti-inflammatory actions. Especially, n-3 PUFA has been shown to exert beneficial effects on some chronic degenerative diseases such as cardiovascular disease, 2, 3 rheumatoid arthritis, 4 diabetes, 5 other autoimmune diseases, 6, 7 and cancer. 8, 9 Increased fat consumption by western diet has been associated with the development of cancer such as breast, colon, pancreatic, and prostate cancers with the notable exception of n-3 PUFA, which show to have multiple beneficial anti-tumor actions that affect the essential alterations that dictate malignant growth in a number of studies. 10 A diet rich in n-3 PUFA may protect from cancer, at least at certain sites. Studies on the fatty acid status of patients with several cancer types including bladder, pancreatic, lung and esophageal cancer show low concentrations of plasma phospholipid n-3 PUFA, ranging from 55 to 88% of amounts in healthy individuals.
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Recent studies have found a positive association between n-6 PUFA and cancer risk, whereas in the same model, n-3
PUFA were shown to reduce the development of cancer.
Epidemiological studies suggest that a high n-3 PUFA to n-6 PUFA ratio may be the optimal strategy to decrease breast cancer risk. 14 Solid epidemiological study shows that consumption of n-3 PUFA appears to protect against the development of hepatocellular carcinoma, even among patients with Hepatitis B Virus (HBV) and/or Hepatitis C Virus (HCV) infection. 15 Recently, Zhennan et al. has reviewed prospective studies investigating the possible protective effects of the dietary intake of n-3 PUFA on prostate cancer development. 16 Fasano et al also has reviewed a lot of in vivo and in vitro experimental studies providing strong indications of the anti-tumor action of n-3 PUFA against lung cancer.
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The purpose of this review is to discuss the potential role of n-3 PUFA in gastrointestinal (GI) cancer development. disproportionally high amounts of n-6 PUFA and low amounts of n-3 PUFA, denoted as a high n-6 to n-3 PUFA ratio, n-3 PUFA may feasibly play a role in several stages of GI cancers management.
Esophageal cancer
Esophageal cancer is ranked as the sixth leading cause of cancer death worldwide. According to the increasing incidence of gastroesophageal reflux disease (GERD), esophageal cancer is a tumor that has increased in incidence more than 7-fold over the past several decades. Recent and n-3 PUFA-containing diet may be beneficial to patients with esophageal cancers who receive chemoradiation therapy (CRT) by reducing CRT toxicity. 21 In contrast to other GI cancer, little work has so far been performed on the influence of n-3 PUFA in oesophageal adenocarcinogenesis and neoplastic progression. 22 There is a need for appropriately powered randomized-controlled studies to assess the long-term benefit of n-3 PUFA.
Gastric cancer
Gastric cancer (GC) is the fourth most common cancer worldwide, and almost two thirds of affected individuals will die of their disease. Some studies about the association of n-3 PUFA and gastric disease suggests a protective effect of n-3 PUFA on gastric cancer. Recently, Correa et al. suggests that docosahexanoic acid (DHA) inhibits Helicobacter pylori (H. pylori) growth in vitro and mice gastric mucosa colonization. 23 H. pylori are recognized as a major etiological factor in chronic active gastritis, gastric duodenal ulcers and gastric cancer. It has been proposed that PUFA hold an inhibitory effect on bacterial growth via disruption of cell membrane leading to bacteria lysis. 24 Mohamed also shows that n-3 PUFA reduced iodoacetamide-induced gastritis in rats through decrease of malondialdehyde (MDA), gastrin, and nitric oxide (NO) and normalization of mucosal glutathione. 25 Especially, it is reported that the erythrocyte composition of DHA was found to be negatively linked to risk of gastric cancer, of well-differentiated adenocarcinoma. 26 Application of a diet enriched with n-3 PUFA delayed tumor growth in a mouse xenograft model. 27 In vitro studies have shown that n-3 PUFA inhibited macrophage-enhanced gastric cancer cell migration and attenuated matrix metalloproteinase (MMP)-10 expression through ERK and STAT3 phosphorylation 28 and inhibited the growth of human gastric carcinoma cell via apoptosis and combination with 5-fluorouracil has synergetic effect in inhibiting the proliferation of gastric cancer cells. 29 Moreover, n-3 PUFA are beneficial for preventing oxidative stress-induced apoptosis by inhibiting apoptotic gene expression and DNA fragmentation of gastric epithelial cells. 30 On the other hand, DHA induced apoptosis of gastric cancer cells by inducing the expression of apoptotic genes in gastric cancer cells. 31 Although a large body of literature spanning numerous cohorts from many countries and with different demographic characteristics does not provide evidence to suggest a significant association between n-3 PUFA and stomach cancer incidence, 32 further studies are needed to investigate action of n-3 PUFA relevant to antitumor effects in the stomach. 33 In meta-analyses of prospective cohort studies that evaluated the association between fish consumption or n-3 fatty acids and colorectal cancer incidence or mortality, the pooled relative risks for colorectal cancer incidence were 0.96~0.97 (95% confidence interval: 0.92, 1.00) for each extra occurrence of fish consumption per week. 34 In a population-based prospective study on the association of n-3 PUFA and cancer, there was an inverse relationship between marine n-3 PUFA intake and the risk of colorectal cancer, but this association was only statistically significant in the proximal site of the large bowel. 35 Cockbain et al. 9 has reviewed a lot of in vitro and in vivo experimental studies and epidemiological observations providing strong indications of the cancer treatment and prevention of n-3 PUFA against colorectal cancer. Kim et al. 36 provided a significant dose-dependent reduction in CRC risk for total n-3 PUFA intake (OR=0.61
for the highest vs lowest quartile), as well as for EPA and DHA intake individually in a case-control study of 1,872
patients (929 cases of distal CRC and 943 controls). Pot measured and compared serum n-3 PUFA levels in 861 patients (363 cases of colorectal adenoma and 498 controls). There was a significant reduction in colorectal adenoma risk (OR=0.67) between low level of n-3 PUFA (＜1.8%) and high level of n-3 PUFA (＞2.3%). 37 Recently, Sorensen et al. 38 reported that n-3 PUFA is incorporated rapidly into colonic mucosa and colonic muscular layer in patients given 3g of n-3 PUFA daily for 7 days before Besides these multiple anti-tumor actions, it is also reported recently that n-3 PUFA can activate Nrf2 and induced Nrf2-directed gene expression 40, 41 and can suppress lipopolysaccharide-induced inflammation through induction of Nrf2 expression. 42 Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive master regulatory transcriptional factor that plays an important protective role in cells by regulating cellular redox balance. 43 Moreover, n-3 PUFA significantly reduces oxidative stressinduced endothelial cell Ca ＋＋ influx. This effect might be associated, at least in part, with altered lipid composition in membrane lipid rafts. 44 1. Useful animal model to study chemopreventive mechanism of n-3 PUFA: Fat-1 transgenic mice model
Recently, the engineered n-3 PUFA desaturase transgenic mice (Fat-1 mice), which can endogenously synthesize n-3 PUFA in their tissues, allows carefully controlled studies to be performed in the absence of potential confounding dietary factors. 45 The synthesis of n-3 PUFA is achieved through the expression of the Fat-1 transgene encoding for an n-3 desaturase, which utilizes n-6 PUFA as substrate.
This allows production of high n-3/n-6 ratios in the animals, thus eliminating the potential diet variations.
Hence, the Fat-1 transgenic mouse is a valuable in vivo system for elucidating the role of n-3 PUFA in carcinogenesis. Since Fat-1 mice were generated, Xia et al. 46 showed that melanoma formation and growth are reduced in Fat-1 (∼30%) and multiplicity (∼33%). 54 Recently, in our laboratory an in vivo study has shown a suppressive effect of in Fat-1 mice. In conclusion, several studies using Fat-1 mice model indicate that balancing the tissue n-6/n-3 ratio could exert a significant effect on GI cancer development.
The fat-1 mouse model allows carefully controlled studies to be performed in the absence of restricted diets, which can create confounding factors that limit studies of this nature. 55 
CONCLUSIONS
GI Cancer incidence and mortality are increasing in the Eastern world and a high n-6 to n-3 PUFA ratio in the Western style diet may be a contributing factor. There is much evidence to suggest that higher consumption of dietary n-3 PUFA is associated with a lower risk of GI cancer in animal models and humans. Especially, recent studies suggest that endogenous n-3 PUFA delay the progression of colon and stomach cancer and elevating n-3
PUFA may be an important strategy to delay/prevent gastrointestinal cancer in high-risk patients via various mechanisms mediating cancer prevention by n-3 PUFA (Fig. 2) . In addition, using n- multi-ethnic population of 20,000 U.S. men aged ≥50 and women aged ≥55. 56 We expect that new findings in combination consumption of n-3 PUFA with other nutrients will provide new approaches to public health implications with regard to prevention of GI cancer through dietary and lifestyle interventions.
